BATS:VMAX

REX VOLMAXX Long VIX WeeklyFutures Strategy ETF Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$18.54
0.00 (0.00 %)
(As of 07/24/2018)
Add
Today's Range
$18.43
$18.72
50-Day Range N/A
52-Week Range
$10.00
$45.20
Volume1,698 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive VMAX News and Ratings via Email

Sign-up to receive the latest news and ratings for REX VOLMAXX Long VIX WeeklyFutures Strategy ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Rex Shares
Fund NameREX VOLMAXX Long VIX WeeklyFutures Strategy ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:VMAX
Inception Date5/2/2016
Fund ManagerDenise M. Krisko
WebN/A
PhoneN/A

Fund Focus

Asset ClassMulti Asset
BenchmarkNot Applicable
CategoryAbsolute Returns
FocusVolatility
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$2.55 million
Average Daily Volume$2,354.00
Discount/Premium-0.24%

ETF Expenses

Management Fee1.25%
Other Expenses1.60%
Total Expenses2.85%
Fee Waiver0.00%
Net Expenses2.85%

Administrator, Advisor and Custodian

AdministratorSEI Investments Global Funds Services
AdvisorExchange Traded Concepts, LLC
CustodianBrown Brothers Harriman & Co.
DistributorSEI Investments Distribution Co.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerVirtu Financial

speech bubbles
speech bubbles











REX VOLMAXX Long VIX WeeklyFutures Strategy ETF (BATS:VMAX) Frequently Asked Questions

What stocks does MarketBeat like better than REX VOLMAXX Long VIX WeeklyFutures Strategy ETF?

Wall Street analysts have given REX VOLMAXX Long VIX WeeklyFutures Strategy ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but REX VOLMAXX Long VIX WeeklyFutures Strategy ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of REX VOLMAXX Long VIX WeeklyFutures Strategy ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other REX VOLMAXX Long VIX WeeklyFutures Strategy ETF investors own include Ally Financial (ALLY), Akari Therapeutics (AKTX), Galiano Gold (AKG), Apollo Investment (AINV), Alamos Gold (AGI), AgroFresh Solutions (AGFS), ADOMANI (ADOM), Ares Commercial Real Estate (ACRE), Acorda Therapeutics (ACOR) and ACADIA Pharmaceuticals (ACAD).

What is REX VOLMAXX Long VIX WeeklyFutures Strategy ETF's stock symbol?

REX VOLMAXX Long VIX WeeklyFutures Strategy ETF trades on the BATS under the ticker symbol "VMAX."

What is REX VOLMAXX Long VIX WeeklyFutures Strategy ETF's stock price today?

One share of VMAX stock can currently be purchased for approximately $18.54.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.